Veterinary Diabetes Market

Veterinary Diabetes Market Overview

The global veterinary diabetesmarket is estimated to be worth over USD 3.65 Bnin 2033 and is expected to grow at CAGR of 6.2% during the forecast period (2024-2033).

The veterinary/animal diabetes care landscape is swiftly evolving, revolutionizing veterinary health market by incorporatinginnovative diagnostic tools, advanced treatments, and improved pet owner education. Diabetes in pets, specifically in dogs and cats, has seen a remarkablesoar, paralleling trends in human health. This sharp rise in diabetes prevalencenecessitates comprehensive management strategies to ensure efficient care. Modernized veterinary practices now employ innovative diagnostic techniques, such as continuous glucose monitoring systems, which offer real-time data on pets' blood sugar levels. These technologies allowaccurate monitoring and improved management of diabetes, enabling for personalized treatment plans that improve the quality of life for diabetic pets.

Avant-garde treatments are also redefining the panorama. Insulin therapy remains the keystone of diabetes management, but novel formulations and delivery techniques, such as long-acting insulins and insulin pumps, are enhancing efficacy and convenience. In addition, the development of specialized diabetic pet foods that control blood sugar levels is a substantial advancement, providing a complementary approach to medication.

The role of pet owners is essentially recognized as vital in administering pet diabetes. Veterinary practices focus on educating owners on identifying symptoms, managing insulin, and maintaining a proper diet and exercise regimen for their pets. Improved awareness and understanding among pet owners result in earlier detection and better management of the disease.

Telemedicine is another transformational factor, allowing regular monitoring and consultations without the necessity for frequent in-person visits. This convenience ensures consistent care and timely adjustments to treatment plans, benefiting both pets and their owners.

All in all, the veterinary diabetes market is characterized by technological advancements, advanced treatments, and a robust focus on pet owner involvement. These changes are transforming veterinary health by enhancing disease management, improving pet quality of life, and fostering a more proactive and informed approach to chronic pet health conditions.

Figure 1. Veterinary Diabetes: Market Size

Get more details on this report - Request Free Sample

Key Market Insights &Current Market Landscape

The global veterinary diabetes market is experiencingnotable growth fuelled by the increasing incidence of diabetes in pets, specifically among cats and dogs, and soaring awareness among pet owners. The market is marked by breakthroughs in diagnostic technologies and treatment alternatives that are improving diabetes management in veterinary practice. Major developments comprise the adoption of continuous glucose monitoring systems, which offer real-time blood sugar data, allowing more accurate and timely interventions. Advancements in insulin therapies, such as long-acting insulins and insulin delivery devices, are also making diabetes management more efficient and convenient.

Novel technologies like telemedicine are revolutionizing the market by supporting regular monitoring and virtual consultations, therebyenhancing access to veterinary care. Specialized diabetic pet foods are another substantial development, providing dietary solutions that aidin controlling blood sugar levels. The market is also witnessinghigher investment in research and development, focused at creating more advanced and pet-friendly treatment alternatives.

Therefore, the global veterinary diabetes market is developing rapidly, led by technological innovations and a greater focus on comprehensive care, which comprises pet owner education and advanced treatment modalities. This dynamic panorama promises better health outcomes for diabetic pets and a more proactive approach to veterinary healthcare.

Market Dynamics

Market Drivers

Increasing Prevalence of Diabetes in Animals

As more animals, particularly companion animals such as cats and dogs, are diagnosed with diabetes, the demand for effective management and treatment solutions has spiked. According to Patterson Veterinary, In 2020, it was estimated that 1 in every 300 dogs and 1 in 230 cats would develop diabetes during their lifetime.This rise in diabetic cases among pets is substantially attributed to factors such as obesity, poor diet, and sluggish lifestyles, imitating similar trends seen in human populations. Since pet owners become more aware of the health issues related to diabetes, there is a soaring focus on early diagnosis and comprehensive management to ensure the well-being of their pets.

This soaring awareness and concern have resulted in a higher demand for advanced diagnostic tools, such as continuous glucose monitoring systems, which offer real-time data and allow more accurate management of the condition. In addition, the market for veterinary insulin therapies, comprising long-acting insulins and advanced delivery devices, is expanding as these treatments become more sophisticated and easier to manage. Specialized diabetic pet foods created to aidregulate blood sugar levels are also gaining momentum, providing pet owners an integrated approach to administering their pets' health.

Veterinary practices are essentiallyemphasizing on educating pet owners about diabetes symptoms, treatment alternatives, and lifestyle adjustments, which is fostering a more proactive approach to pet healthcare. In addition, the adoption of telemedicine in veterinary care is supporting better disease management through regular monitoring and virtual consultations, improving access to veterinary services.

Thus, the increasing prevalence of diabetes in pet animals is fuelling significant growth in the veterinary diabetes market, as it spurs advancements in diagnostics, treatments, and comprehensive care strategies, ultimately enhancing health outcomes for diabetic pets.

Market Restraints

With regard to numerous advantages of Veterinary Diabetes, the market faces several challenges due to the unique characteristics and requirements associated with these potent pharmaceutical products. Some of the key market challenges include:

1. High Cost of Treatment and Diagnostic Tools: Managing diabetes in pets can be expensive due to the high costs associated with diagnostic tools such as continuous glucose monitoring systems, as well as insulin therapies and specialized diabetic pet foods. These costs can be prohibitive for many pet owners, limiting the widespread adoption of advanced diabetes management solutions. Consequently, the financial burden acts as a significant restraint on market growth, particularly in regions with lower disposable incomes.
2. Limited Awareness and Knowledge Among Pet Owners: Regardless of thegrowing awareness, a substantial number of pet owners remain oblivious of the symptoms, causes, and proper management of diabetes in pets. This deficiency of knowledge can result indeferred diagnosis and inadequate treatment, limiting the effectiveness of diabetes management. In addition, the intricacy of administering a chronic condition like diabetes requires consistent education and support from veterinary professionals, which are likely to not always be readily available or accessible, further restraining market growth.

Get more details on this report - Request Free Sample

Market Opportunity

Launch of User-Friendly Products

The launch of user-friendly products stands as a significant market opportunity for the global veterinary diabetes characterized by substantiallyimproving the ease and efficacy of diabetes management for both pet owners and veterinary professionals. User-friendly products, such as streamlined insulin delivery devices, instinctive glucose monitoring systems, and easy-to-administer diabetic pet foods, address the challenges related to the complicated and often formidable task of administering diabetes in pets. For instance, advancements like insulin pens and pumps designed particularly for pets streamline the administration process, minimizing the stress and complexity for pet owners, and ensuring more consistent and precise dosing.

Parallelly, innovative glucose monitoring systems that are less invasive and offer real-time data through user-friendly associatesallow pet owners to track their pets’ blood sugar levels more effectively. These systems often come with digital platforms or apps that facilitates data collection and sharing with veterinarians, supportingimprovedcontinuous management and timely adjustments to treatment plans.

In addition, the development of palatable and nutritionally balanced diabetic pet foods aidscontrol pets' blood sugar levels while ensuring they receive the needed nutrients. These user-friendly dietary solutions make it easier for pet owners to cohere to prescribed diets, enhancing overall disease management.

Market Trends

1. Synthesis of Telemedicine and Digital Health Platforms: The global veterinary diabetes market is essentially adopting telemedicine and digital health platforms to improve diabetes management. These technologies allow remote monitoring of pets' health, enabling veterinarians to offer timely advice and adjust treatment plans based on real-time data. Telemedicine facilitates more frequent and convenient check-ins, reducing the need for in-person visits and improving access to veterinary care, especially in remote or underserved areas. Digital health platforms often come with user-friendly interfaces that help pet owners track their pets' glucose levels, medication schedules, and dietary adherence, resultingin better disease management and health outcomes.
2. Advancements in Continuous Glucose Monitoring Systems: Another major trend in the veterinary diabetes market is the development and adoption of advanced continuous glucose monitoring (CGM) systems. These systems provide real-time, precise monitoring of blood glucose levels, minimizing the necessity for frequent blood samples and providing a more comprehensive picture of a pet’s glucose fluctuations. Advanced CGM devices are becoming more user-friendly, with features such as app integration, wireless connectivity, and automated alerts, which make it simpler for pet owners to administer their pets' diabetes. These advancements not only enhance the quality of life for diabetic pets but also improve the ability of veterinarians to make informed treatment decisions, fuelling greater market adoption of CGM technology.

Veterinary Diabetes Market: Key Segments

By Drug Type

• Insulin Therapy
• Oral Medication

By Device Type

• Glucose Monitoring Devices
• Insulin Delivery Devices

By Animal Type

• Canine
• Feline

By Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America

Veterinary Diabetes Market: Segmental Analysis

On the basis of drug type, the global veterinary diabetesmarket is segmented into Insulin Therapy, Oral Medication. Insulin therapyhold the dominant share due to its crucial role in managing diabetes, specifically in dogs and cats who time and again require insulin to control blood glucose levels effectively. Insulin therapy is the most reliable and widely accepted treatment, as oral medications are generally less effective in animals. In addition, advancements in insulin formulations and delivery methods have made it easier and more effective for pet owners to administer, further solidifying its market dominance.

Figure 4. Veterinary Diabetes Market: Distribution by Region

Get more details on this report - Request Free Sample

Veterinary Diabetes Market: Regional Analysis

In North America region the rising pet adoption and increasing expenditure on them are expected to boost the overall growth of the market. The region also benefits from substantial investments in veterinary research and the availability of innovative diabetes management products. Along with that, a strong focus on early diagnosis and comprehensive pet care further fuels the demand for veterinary diabetes treatments in North America.

Veterinary Diabetes Market: Recent Developments

• In August 2023, Boehringer Ingelheim announced that SENVELGO® (velagliflozin oral solution), a revolutionary new treatment for cats with diabetes, has been approved by the U.S. Food and Drug Administration (FDA). SENVELGO® is a once-daily liquid oral solution that cat owners can give with a small amount of food or directly into the cat’s mouth. 

Leading Veterinary Diabetes Developers

Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and future opportunities associated with the Veterinary Diabetes market, during the given forecast period. Further, the market report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the biopharmaceutical industry. Key takeaways of the Veterinary Diabetes market are briefly discussed below.

The report includes the list of players operating in the global veterinary diabetesmarket. Some of the key players include:

• Allison Medical
• Apotex Inc.
• Becton
• Boehringer Ingelheim Vetmedica Inc.
• Dickinson and Company
• Henry Schein Animal Health
• MED TRUST
• Merck & Co. Inc
• UltiMed Inc.
• Zoetis Inc.

Scope of the Report

The market report presents an in-depth analysis of the various firms / organizations that are engaged in this market, across different segments, as defined in the below table: